Blinatumomab/MethotrexateGrade3/4 neurotoxicity and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2027卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67287-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：98 / 98

相关论文

共 50 条

[31] RituximabHypogammaglobulinaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2054 (1) : 393 - 393
[32] HydroxycarbamideMyelosuppression and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1965 (1) : 233 - 233
[33] AspirinHaemorrhage and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1980 (1) : 64 - 64
[34] RiociguatHaemoptysis and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1847 (1) : 396 - 396
[35] SiltuximabPolycythaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2031 (1) : 359 - 359
[36] AntineoplasticsSepsis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1912 (1) : 69 - 69
[37] AntineoplasticsThrombocytopenia and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1967 (1) : 56 - 56
[38] MethotrexateKeratopathy and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 311 - 311
[39] AntineoplasticsHypomagnesaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1956 (1) : 60 - 60
[40] DenosumabOedema and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1974 (1) : 128 - 128

← 1 2 3 4 5 →